Evoke Pharma Net Cash Flow 2012-2024 | EVOK
Evoke Pharma net cash flow from 2012 to 2024. Net cash flow can be defined as the total change in cash for the company over the given period.
Evoke Pharma Annual Net Cash Flow
(Millions of US $) |
| 2024 |
$9 |
| 2023 |
$-5 |
| 2022 |
$1 |
| 2021 |
$1 |
| 2020 |
$2 |
| 2019 |
$0 |
| 2018 |
$-2 |
| 2017 |
$-1 |
| 2016 |
$0 |
| 2015 |
$-5 |
| 2014 |
$-10 |
| 2013 |
$24 |
| 2012 |
$-1 |
| 2011 |
$-3 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-GENERIC DRG |
$0.004B |
$0.010B |
|
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|
